Aurinia PharmaceuticalsAUPH 
$7.06-1.12%24h
-1.12%24h
Global rank7794
Market cap$1.01B
Change 7d1.88%
YTD Performance-20.32%
SP500 benchmarkUnderperform
P/E-13.07
P/S5.76
Revenue$175.51M
Earnings-$78.02M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Aurinia Pharmaceuticals (AUPH)
Aurinia Pharmaceuticals has an EPS of $-0.54. In 2022, the company made an earnings per share (EPS) of $-0.76. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for AUPH
-
Value:-
EPS history for Aurinia Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.54 | -28.95% |
| 2022 | -$0.76 | -45.71% |
| 2021 | -$1.40 | 60.92% |
| 2020 | -$0.87 | - |
View the highest EPS stocks
